We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Platelet-Function Analyzer Predicts Heart Damage

By HospiMedica staff writers
Posted on 18 Nov 2004
A study has shown that a platelet-function analyzer may predict myocardial damage and also aid in risk stratification of heart-attack patients. More...
The finding was reported in the September 14, 2004, issue of Circulation.

The study indicated that patients with ST-segment-elevation myocardial infarction (STEMI) show significantly enhanced platelet function when their platelets are subjected to shear conditions similar to those found in a stenosed coronary artery by a platelet-function analyzer. Platelet activation is a hallmark of acute coronary syndromes, and this evidence suggests a link between platelet hyperfunction and myocardial damage in patients with acute coronary syndromes. Platelet function results at presentation were found to be independent predictors of the severity of heart damage as measured by creatine-kinase myoglobin (CK-MB) or troponin.

The analyzer used in the study was the PFA-100 platelet-function analyzer of Dade Behring (Deerfield, IL, USA). "This potential role for PFA-100 means this product could join Dade Behring's wide portfolio of cardiac assay and instrument systems as a diagnostic tool for myocardial infarction,” said Mark Wolsey-Paige, senior vice president, strategy and technology, at Dade Behring.




Related Links:
Dade Behring

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.